Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» Four months after patient death, FDA’s hold lifted on Alnylam’s fitusiran
Four months after patient death, FDA’s hold lifted on Alnylam’s fitusiran
Four months after patient death, FDA’s hold lifted on Alnylam’s fitusiran
Submitted by
admin
on December 15, 2017 - 9:32am
Source:
Endpoints
News Tags:
patients
FDA
Alnylam
fitusiran
Headline:
Four months after patient death, FDA’s hold lifted on Alnylam’s fitusiran